Lupin Share Price Target 2024, 2025, 2030, 2040, 2050
Lupin is one of the largest Indian pharmaceutical companies which makes and sells a variety of medicines at very affordable prices. The company is well known for its medicine for diabetes, heart problems, lung conditions, and mental health.
The company do business in the country and it supplies its product to the outside of the country.
What is Lupin Ltd NSE: LUPIN?
Contents
- 1 What is Lupin Ltd NSE: LUPIN?
- 2 Lupin Share Price Target Tomorrow
- 3 Lupin Share Price Target 2024
- 4 Lupin Share Price Target 2025
- 5 Share Price Target 2030
- 6 Share Price Target 2040
- 7 Share Price Target 2050
- 8 Should I Buy Lupin Stock?
- 9 Lupin Ltd Earning Results
- 10 Is Lupin Stock Good to Buy? (Bull case & Bear case)
- 11 Conclusion
- 12 FAQs
Lupin Limited is an Indian company that makes a wide range of medicines including, biosimilars, generic drugs, and over-the-counter (OTC) medicines in over 100 countries like the U.S., India, South Africa, Asia, Latin America, Europe, and the Middle East. The company is well-known for its medicines for diabetes, heart problems, and breathing issues, as well as treatments for infections, stomach problems, and brain health. It was established in 1968 by Desh Bandhu Gupta.
The stock is currently in an uptrend but this rise seems to be getting weaker. The price is below the important level of 2216 on the chart. If it stays below this level, the stock might fall in the short term. For tomorrow, the stock may be moved sideways as there is no big trade by the company. It’s a good idea to wait and see how it performs in the first half of the day. If it shows weakness later in the day, this trend might continue. If it shows strength, the trend could continue in the next trading session.
The price would be between ₹2198 to ₹2275 in 2024.
| Year | Minimum target (Rs) | Maximum target (Rs) |
| 2024 | -28 | +35 |
The company began with many challenges. The founder started the company by borrowing ₹5,000 from his wife, and later it did very well. The company has grown very well. It does business outside the country too. In the last 15 years, it has expanded to over 70 countries. Experts in India think that by 2024, Lupin’s share price target would be ₹2600.
In 2024, its share price would be between ₹1300 to ₹2600.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2024 | 1300 | 2600 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 1300 | 1420 |
| February | 1484 | 1692 |
| March | 1544 | 1696 |
| April | 1534 | 1677 |
| May | 1550 | 1720 |
| June | 1480 | 1692 |
| July | 1591 | 1925 |
| August | 1900 | 2256 |
| September | 2185 | 2360 |
| October | 2100 | 2468 |
| November | 2120 | 2480 |
| December | 2132 | 2600 |
Looking for further years then its fundamental is very good the stock has given very good returns in past. Lupin’s market cap is looking strong. The company has very low debt, with a debt-to-equity ratio of 0.20, meaning it has very little debt and could give good returns in the future. Also in recent years, the stock has performed very well. Experts think that in 2025, its share price target would be ₹3240.
In 2025, its share price would be between ₹2200 to ₹3240.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2025 | 2200 | 3240 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 2276 | 2784 |
| February | 2213 | 2760 |
| March | 2250 | 2790 |
| April | 2200 | 2848 |
| May | 2230 | 2860 |
| June | 2257 | 2895 |
| July | 2290 | 2964 |
| August | 2327 | 2980 |
| September | 2300 | 3057 |
| October | 2376 | 3122 |
| November | 2350 | 3130 |
| December | 2413 | 3240 |
This company has grown fast in India because it makes good medicines that people need. It also provides many heart medicines, which has helped it expand to over 70 countries. As it is a very old company, people trust this company’s products. It has a very strong brand value in the market. Its stock price faced many ups and downs but ultimately for the long-term investors it gave a good profit. It is one of the top companies in the medical sector. For the year 2030, its share price target would be ₹6400.
By 2030, its share price would be between ₹5500 to ₹6400.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2030 | 5500 | 6400 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 5500 | 5631 |
| February | 5567 | 5670 |
| March | 5600 | 5700 |
| April | 5550 | 5760 |
| May | 5640 | 5800 |
| June | 5700 | 5930 |
| July | 5840 | 5900 |
| August | 5890 | 6100 |
| September | 5940 | 6173 |
| October | 6000 | 6250 |
| November | 6123 | 6300 |
| December | 6280 | 6400 |
As India’s population grows, people are getting sick more often and need more medicine. To meet this demand, the company is expanding its production and opening new branches. The company makes over 180 medicines and is the third-largest drug company in India. On the other hand, The company has given a more than 100% return over the last 5 years. The company could offer very good returns in the future. If the company keeps growing and managing well, it could give very good returns. In 2040, its share price target would be ₹8900.
By 2040, its share price would be between ₹8100 to ₹8900.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2040 | 8100 | 8900 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 8100 | 8230 |
| February | 8185 | 8280 |
| March | 8200 | 8346 |
| April | 8267 | 8350 |
| May | 8290 | 8400 |
| June | 8330 | 8450 |
| July | 8300 | 8570 |
| August | 8450 | 8683 |
| September | 8546 | 8712 |
| October | 8621 | 8767 |
| November | 8715 | 8780 |
| December | 8825 | 8900 |
The company is known for its quality and genuine pricing. It’s not only known in India but in the foreign country, and its medicine is in high demand. It made medicine for major diseases like heart attacks, mental health, diabetes and so on. At the current time, it is one of the biggest brands in the medical line. The company gained much trust from the people. So in the coming year, its share price will be seen to be on an uptrend. In 2050, its stock price target would be ₹14000.
In 2050, its share price could be between ₹12200 to ₹14000.
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2050 | 12200 | 14000 |
| Month | Minimum Price (Rs) | Maximum Price (Rs) |
| January | 12200 | 12357 |
| February | 12270 | 12442 |
| March | 12340 | 12530 |
| April | 12400 | 12631 |
| May | 12540 | 12738 |
| June | 12609 | 12900 |
| July | 12690 | 13030 |
| August | 12875 | 13100 |
| September | 13056 | 13360 |
| October | 13400 | 13625 |
| November | 13600 | 13831 |
| December | 13780 | 14000 |
Should I Buy Lupin Stock?
| Year | Minimum Price (Rs) | Maximum Price (Rs) |
| 2024 | 1300 | 2600 |
| 2025 | 2200 | 3240 |
| 2030 | 5500 | 6400 |
| 2040 | 8100 | 8900 |
| 2050 | 12200 | 14000 |
The company’s best-selling medicines include drugs for diabetes, infections, heart problems, and asthma. This company also makes and sells brand-name drugs like Lupitac, Metoject, and Lupizole. If you want to invest in a pharma company or are thinking about it, Lupin stock could be a good option for you. In the past year, Lupin stock has gone up by over 100%, making investors very happy.
Lupin Ltd Earning Results
| Mcap Full (Cr.) | 1,02,441.62 |
| Turnover (Cr.) | 19.43 |
| TTQ (Lakh) | 0.86 |
| EPS (TTM) | 60.06 |
| CEPS (TTM) | 75.99 |
| PE/PB | 36.78 / 4.89 |
| ROE | 13.29 |
| Face Value | 2.00 |
| NPM % | 21.34 |
| OPM % | 29.70 |
| Cash EPS | 22.60 |
| EPS | 19.51 |
| Revenue | 4,167.63 |
| Net Profit | 889.18 |
Is Lupin Stock Good to Buy? (Bull case & Bear case)
Bull Case :
- it is growing well, with new medicines and expanding in global markets.
- It has shown better sales and profits recently, giving strong returns to investors.
- There is increasing demand for medicines worldwide, especially for cheaper, generic drugs, which Lupin makes a lot of.
Bear Case :
- It faces strict rules in different countries. If they fail to meet these rules, they could face fines or bans.
- There are many other companies making similar medicines.
Conclusion
In this article, we give you all the important information about Lupin. If you are planning to invest in its share or have already invested, this article can be very helpful. We discussed everything from the basics of the company to its future plans and analysis. we have given you the multiple time frame price prediction so please read the whole article to know in depth.
